NPI: 1669842407 · NORFOLK, VA 23502 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/06/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/06/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,369 | $194K |
| 2019 | 7,348 | $118K |
| 2020 | 9,827 | $156K |
| 2021 | 6,441 | $156K |
| 2022 | 3,125 | $137K |
| 2023 | 1,373 | $128K |
| 2024 | 1,177 | $33K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 14,942 | 1,119 | $889K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 13,010 | 649 | $24K |
| J1756 | Injection, iron sucrose, 1 mg | 1,802 | 387 | $3K |
| A4657 | Syringe, with or without needle, each | 1,722 | 681 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,699 | 503 | $3K |
| G0008 | Administration of influenza virus vaccine | 18 | 13 | $533.63 |
| 83970 | 186 | 134 | $12.79 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 46 | 25 | $3.74 |
| 82728 | 152 | 109 | $2.06 | |
| 85041 | 329 | 231 | $1.59 | |
| 85048 | 329 | 231 | $1.34 | |
| 83550 | 150 | 107 | $1.33 | |
| 83540 | 150 | 107 | $0.98 | |
| 90674 | 18 | 13 | $0.92 | |
| 82108 | 107 | 79 | $0.92 |